Terms: = Endocrine gland cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534
18 results:
1. Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications.
Park JK; Jeong HO; Kim H; Choi JH; Lee EM; Kim S; Jang J; Choi DW; Lee SH; Kim KM; Jang KT; Lee KH; Lee KT; Lee MW; Lee JK; Lee S
Mol Cancer; 2024 May; 23(1):87. PubMed ID: 38702773
[TBL] [Abstract] [Full Text] [Related]
2. Transcription factor etv1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial-mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize etv1 expression.
Weng H; Feng W; Li F; Huang D; Lin L; Wang Z
Growth Factors; 2023 Aug; 41(3):152-164. PubMed ID: 37428861
[TBL] [Abstract] [Full Text] [Related]
3. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
4. Contrast-enhanced ultrasound and contrast-enhanced computed tomography for differentiating mass-forming pancreatitis from pancreatic ductal adenocarcinoma: a meta-analysis.
Yang J; Huang J; Zhang Y; Zeng K; Liao M; Jiang Z; Bao W; Lu Q
Chin Med J (Engl); 2023 Sep; 136(17):2028-2036. PubMed ID: 36728948
[TBL] [Abstract] [Full Text] [Related]
5. Nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy: A real-world experience.
Yu HY; Lee CY; Lin LG; Chao Y; Li CP
J Chin Med Assoc; 2022 Jan; 85(1):42-50. PubMed ID: 34759212
[TBL] [Abstract] [Full Text] [Related]
6. The Association Between Testicular Self-Examination and Stages of Testicular cancer Diagnosis: A Cross-Sectional Analysis.
Rovito MJ; Adams WB; Craycraft M; Gooljar C; Maresca M; Guelmes J; Gallelli A
J Adolesc Young Adult Oncol; 2022 Feb; 11(1):41-47. PubMed ID: 33877917
[No Abstract] [Full Text] [Related]
7. Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group.
Sangnier E; Ouldamer L; Bendifallah S; Huchon C; Collinet P; Bricou A; Mimoun C; Lecointre L; Graesslin O; Raimond E
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101961. PubMed ID: 33127559
[TBL] [Abstract] [Full Text] [Related]
8. Frequent copy number gains of SLC2A3 and etv1 in testicular embryonal carcinomas.
Hoff AM; Kraggerud SM; Alagaratnam S; Berg KCG; Johannessen B; Høland M; Nilsen G; Lingjærde OC; Andrews PW; Lothe RA; Skotheim RI
Endocr Relat Cancer; 2020 Sep; 27(9):457-468. PubMed ID: 32580154
[TBL] [Abstract] [Full Text] [Related]
9. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract] [Full Text] [Related]
10. Reclassification of
Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW
J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210
[TBL] [Abstract] [Full Text] [Related]
11. Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary Thyroid cancer.
Kim Y; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2017 Nov; 24(12):3609-3616. PubMed ID: 28822118
[TBL] [Abstract] [Full Text] [Related]
12. Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers.
Yoshikawa T; Takano M; Miyamoto M; Yajima I; Shimizu Y; Aizawa Y; Suguchi Y; Moriiwa M; Aoyama T; Soyama H; Goto T; Hirata J; Suzuki A; Sasa H; Nagaoka I; Tsuda H; Furuya K
Cancer Chemother Pharmacol; 2017 Sep; 80(3):555-561. PubMed ID: 28726081
[TBL] [Abstract] [Full Text] [Related]
13. Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors.
Matsuo K; Machida H; Takiuchi T; Grubbs BH; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2017 Mar; 144(3):496-502. PubMed ID: 28131526
[TBL] [Abstract] [Full Text] [Related]
14. TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes.
Vinagre J; Nabais J; Pinheiro J; Batista R; Oliveira RC; Gonçalves AP; Pestana A; Reis M; Mesquita B; Pinto V; Lyra J; Cipriano MA; Ferreira MG; Lopes JM; Sobrinho-Simões M; Soares P
Sci Rep; 2016 Jul; 6():29714. PubMed ID: 27411289
[TBL] [Abstract] [Full Text] [Related]
15. Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel.
Roque DM; Buza N; Glasgow M; Bellone S; Bortolomai I; Gasparrini S; Cocco E; Ratner E; Silasi DA; Azodi M; Rutherford TJ; Schwartz PE; Santin AD
Clin Exp Metastasis; 2014 Jan; 31(1):101-10. PubMed ID: 24005572
[TBL] [Abstract] [Full Text] [Related]
16. Integrative epigenomic and genomic analysis of malignant pheochromocytoma.
Sandgren J; Andersson R; Rada-Iglesias A; Enroth S; Akerstrom G; Dumanski JP; Komorowski J; Westin G; Wadelius C
Exp Mol Med; 2010 Jul; 42(7):484-502. PubMed ID: 20534969
[TBL] [Abstract] [Full Text] [Related]
17. Rare association of adrenal tumors.
Tica I; Tica VI; Mihailov C
Rom J Intern Med; 2007; 45(1):107-11. PubMed ID: 17966451
[TBL] [Abstract] [Full Text] [Related]
18. HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein er81.
Dowdy SC; Mariani A; Janknecht R
J Biol Chem; 2003 Nov; 278(45):44377-84. PubMed ID: 12947087
[TBL] [Abstract] [Full Text] [Related]
